EE711 Cost Effectiveness of Intravenous Versus Oral Cytomegalovirus Treatment in Recipients of Allogeneic Hematopoietic Cell Transplant From Tunisian Hospital Perspective
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.991
https://www.valueinhealthjournal.com/article/S1098-3015(24)03854-3/fulltext
Title :
EE711 Cost Effectiveness of Intravenous Versus Oral Cytomegalovirus Treatment in Recipients of Allogeneic Hematopoietic Cell Transplant From Tunisian Hospital Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03854-3&doi=10.1016/j.jval.2024.10.991
First page :
Section Title :
Open access? :
No
Section Order :
10481